Clinuvel Pharmaceuticals LimitedASX: CUV

Change in substantial holding - Updated

· Issued by Clinuvel Pharmaceuticals Limited via ASX

Filed with ASX · · 32 pages · English

Release

604 Page 1 of 5 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company Name/Scheme CLINUVEL PHARMACEUTICALS LTD ACN/ARSN/ABN 88 089 644 119 1. Details of substantial holder (1) Name JPMorgan Chase & Co. and its affiliates ACN/ARSN (if applicable)...

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

All Clinuvel Pharmaceuticals news releases